ARTICLE | Clinical News
Treakisym bendamustine: Completed Phase II enrollment
March 11, 2013 7:00 AM UTC
SymBio completed enrollment of 70 patients in an open-label, Japanese Phase II trial comparing Treakisym plus rituximab vs. R-CHOP chemotherapy (rituximab, cyclophosphamide, doxorubin, vincristine and...